Woman who sold Matthew Perry fatal drugs to be sentenced

Jasveen Sangha pleaded guilty to selling the actor the ketamine that killed him in 2023.

Apr. 8, 2026 at 1:54pm

Got story updates? Submit your updates here. ›

A woman who admitted to selling Matthew Perry the ketamine that killed him in 2023 is set to be sentenced on Wednesday. Jasveen Sangha, who prosecutors have dubbed the 'Ketamine Queen,' will be the third defendant sentenced of the five people who have pleaded guilty in connection with the 54-year-old actor's overdose death.

Why it matters

Perry's death highlighted the ongoing opioid crisis and the dangers of illegal drug distribution, especially to high-profile clients. The case has also raised questions about how to hold drug dealers accountable when their products lead to fatal overdoses.

The details

Sangha, a 42-year-old dual U.S.-U.K. citizen, pleaded guilty to charges including distribution of ketamine resulting in death. Prosecutors are asking for a 15-year prison sentence, casting her as the leader of an elaborate drug operation catering to wealthy clients. Sangha's lawyers argue the time she has already spent in jail should be sufficient, citing her lack of a criminal record and exemplary behavior as an inmate.

  • Sangha will be sentenced on Wednesday, April 9, 2026.
  • Perry was found dead in his Los Angeles home in 2023, with the medical examiner ruling ketamine as the primary cause of death.
  • Sangha was indicted in August 2024 for her role in Perry's death.

The players

Jasveen Sangha

A woman who admitted to selling Matthew Perry the ketamine that killed him in 2023. Prosecutors have dubbed her the 'Ketamine Queen' and allege she ran an elaborate drug operation catering to high-end clients.

Matthew Perry

The 54-year-old actor best known for his role as Chandler Bing on the TV show 'Friends,' who died of a ketamine overdose in 2023.

Got photos? Submit your photos here. ›

What’s next

Members of Perry's family are expected to speak in court before Sangha's sentencing on Wednesday.

The takeaway

This case highlights the ongoing opioid crisis and the challenges of holding drug dealers accountable when their products lead to fatal overdoses, especially among high-profile clients.